According to a new report published by Allied Market Research, titled, “Global Thermoluminescent Dosimeter (TLD) Services Market by Type, Industry, and Dosimetry Service: Opportunity Analysis and Industry Forecast, 2019–2026,” the global thermoluminescent dosimeter (TLD) services market size was valued at $405.9 million in 2018, and is projected to reach $1,335.9 million by 2026, registering a CAGR of 17.1% from 2019 to 2026. A thermoluminescent dosimeter (TLD) is a device that measures ionizing radiations by assessing the intensity of light emitted from the crystal present inside the dosimeter. When heated, the device releases the trapped electrons in the form of light that is evaluated by a TLD reader. This helps in measuring the exact intensity of the ionizing radiation. TLD finds its application in medical institutions, health physics, nuclear research & industry, and others, due to its accuracy and capability of measuring radiation exposure. These devices are majorly used in industries where workers are exposed to radiations, wherein they protect workers from exposure to radiations and in cases of accidental radiation leakage. Furthermore, they are used in cancer treatments in which radiation inhibits the growth of cancerous cells.
Rise in demand for dosimeters in medical industries for cancer treatments and increase in usage of radioactive materials in the fields of research, defense, and power production are the factors that fuel the growth of the global thermoluminescent dosimeter (TLD) services market. Moreover, companies are significantly investing in developing devices that are capable for measuring radioactive materials, thereby boosting the growth of the thermoluminescent dosimeter (TLD) services market across the globe. In addition, enforcement of stringent occupational safety regulations and mandates by the Joint Coordination Committee formed by the regulatory bodies globally for National Dose Registry (NDR) fuels the thermoluminescent dosimeter (TLD) services market growth. However, availability of potent alternatives, i.e., electronic personal dosimeters (EPDs) is expected to restrain the growth of the market.
The global thermoluminescent dosimeter (TLD) services market is segmented into type, industry, dosimetry service, and region. By type, the market is classified into calcium fluoride TLD and lithium fluoride TLD. The calcium fluoride segment was the highest contributor to the market in 2018, as Calcium fluoride TLDs are suitable for high dose dosimetry & environmental applications. Since, these TLDs are used for measuring and recording gamma exposure and exhibit greater sensitivity at times when compared to lithium fluoride TLDs, they are usually preferred in mining and areas where workers are exposed to gamma radiations. Moreover, companies such as Thermofisher Scientific, RADCARD, and Vinten Instruments Ltd. are increasingly investing in manufacturing and R&D of calcium fluoride TLDs, which acts as a key factor that drives the market growth. On the basis of industry, it is segregated into nuclear industries, medical industries, research institutions, safety & security industries, health physics industries, and mining industries. Increasing use of medical dosimetry for therapeutic procedures such as diagnostics X-rays, radiation therapy, and clinical nuclear medicine is expected to drive the medical industry segment. According to dosimetry service, it is fragmented into whole-body X-ray badges, extremity dosimetry, environmental/area dosimetry, and others. The whole-body X-ray badges segment dominated the market in 2018, and is anticipated to maintain its dominance throughout the forecast period. This is attributed to the economic cost and enhanced reliability of badges and increase in their usage in nuclear facilities, safety & security industries, medical & research institutions, and mining.Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.North America is projected to grow at a high pace during the forecast period. This is attributed to significant increase use of dosimeters in the medical industry and at industrial sites where workers are at high risk to be exposed to high-energy radiation. U.S. dominated the North American market in 2018, and is anticipated to continue this trend during the forecast period, owing to the presence of major TLD service providers. Furthermore, the major factor driving the growth of thermoluminescent dosimeter (TLD) services in Asia-Pacific region includes increase in government opportunities toward limiting radiation exposure and increase in awareness of safety & security required from radiation sources among the population.
Key Findings Of The Study
By type, the lithium fluoride TLD segment occupied 64.7% share of the global thermoluminescent dosimeter (TLD) services market in 2018.
The medical industry segment accounted for 30.1% share of the thermoluminescent dosimeter (TLD) services market in 2018.
The environmental/area dosimeter segment is anticipated to grow at the 16.3% during the analysis period.